Filing Details

Accession Number:
0001209191-22-014952
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-02 17:28:59
Reporting Period:
2022-02-28
Accepted Time:
2022-03-02 17:28:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Medical Laboratories (8071) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306119 T Kevin Conroy C/O Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-28 20,575 $0.00 935,971 No 4 M Direct
Common Stock Acquisiton 2022-02-28 9,312 $0.00 945,283 No 4 M Direct
Common Stock Disposition 2022-03-01 14,299 $76.69 930,984 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-02-28 20,575 $0.00 20,575 $0.00
Common Stock Restricted Stock Units Disposition 2022-02-28 9,312 $0.00 9,312 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
9,312 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 26,574 Indirect Held in 401(k) Plan
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,729 Indirect Held in Grantor Retained Annuity Trust
Footnotes
  1. Represents shares of common stock received upon vesting of a restricted stock unit award.
  2. Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 28, 2022.
  3. In addition to the shares of Common Stock reported on this Form 4, which total 1,022,747 shares, Mr. Conroy also holds, in the aggregate, an additional 998,063 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  4. Each restricted stock unit represents a contingent right to receive one share of common stock.
  5. Represents a restricted stock unit award that partially vested on February 28, 2022. The restricted stock units vest in four equal annual installments beginning on February 27, 2019.
  6. Represents a restricted stock unit award that partially vested on February 28, 2022. The restricted stock units vest in four equal annual installments beginning on February 26, 2020.